Latest News by Industry
SAN DIEGO (AP) — SAN DIEGO (AP) — Gossamer Bio Inc. (GOSS) on Thursday reported a loss of $30.8 million in its third quarter.
The San Diego-based company said it had a loss of 14 cents per share.
The results topped Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 18 cents per share.
The biopharmaceutical company posted revenue of $9.5 million in the period, which also beat Street forecasts. Four analysts surveyed by Zacks expected $4.5 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GOSS at https://www.zacks.com/ap/GOSS